The molecular pathogenesis of DMD involves disrupted dystrophin–glycoprotein complex (DGC) formation, which compromises the structural integrity of the sarcolemma and precipitates dysregulation of the mechanotransduction pathway. This evidence concerns the gene DMD and Duchenne muscular dystrophy.